The Mortality Gap in Neurodevelopmental Care: Why Young Adults with ASD, ID, and CP Face Higher Risks

The Crisis of Transition: Addressing Mortality in Neurodevelopmental Disabilities

For decades, clinical attention for neurodevelopmental disabilities (NDDs) such as autism spectrum disorder (ASD), intellectual disability (ID), and cerebral palsy (CP) has been heavily weighted toward early diagnosis and pediatric intervention. However, as medical advancements have improved survival rates into adulthood, a new clinical challenge has emerged: the ‘cliff’ of adult care. A recent comprehensive study published in JAMA Pediatrics by Shaw et al. provides a sobering assessment of mortality among youth and young adults with these conditions, offering a critical roadmap for clinicians and health policy experts to address persistent health disparities.

Historically, mortality data for NDD populations in the United States have been fragmented. The lack of robust, population-based longitudinal data has made it difficult to quantify the specific risks faced by these individuals as they transition from the structured environment of pediatric care to the often-fragmented adult healthcare system. The findings from this latest surveillance study underscore a significant and multifaceted mortality gap that requires immediate clinical and systemic attention.